# Gene Prediction Tools Market > Gene Prediction Tools Market Research Report Information By Component (Software and Service), by Application (Drug Discovery & Designing, Diagnostics, and Other Applications), by End-user (Research & Academic Institutes, Biotechnology Companies, Hospitals & Clinics, and Diagnostic Laboratories), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 18.2% - **2024:** $ 0.25 Billion - **2025:** $ 0.29 Billion - **2035:** $ 1.56 Billion - **Key Players:** Illumina (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Bio-Rad Laboratories(US), Qiagen (DE), Ginkgo Bioworks (US), Boehringer Ingelheim (DE), Genomatix (DE), DNAnexus (US), Geneious (NZ) **Report ID:** MRFR/LS/20271-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/gene-prediction-tools-market-21869 --- ## Market Summary ## **Gene Prediction Tools Market Overview** As per MRFR analysis, the Gene Prediction Tools Market Size was estimated at 0.25 (USD Billion) in 2024. The Gene Prediction Tools Market Industry is expected to grow from 0.29 (USD Billion) in 2025 to 1.32 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 18.20% during the forecast period (2025 - 2034). Advances in genomics research, increased use of personalized medicine, and rising demand for bioinformatics solutions are expected to be significant market drivers for gene prediction tools. Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **Gene Prediction Tools Market Trends** ### **Rising demand for personalized medicines and growing applications of genomics are driving the market growth** Market CAGR for gene prediction tools is driven by the rising demand for personalized medicines and growing applications of genomics. The growing demand for personalized medicine has been a catalyst for the advancement of gene prediction tools. These tools leverage genetic information to forecast an individual's susceptibility to certain diseases, their response to specific medications, and potential adverse reactions. By analyzing an individual's genetic data, gene prediction tools can identify variations linked to diseases or drug metabolism, thus assisting in tailoring treatment plans. Additionally, numerous collaborations among researchers and industry stakeholders are expected to positively influence market growth. For instance, in February 2022, Genomic Medicine Sweden (GMS) and the Centers for Personalized Medicine (ZPM) in Germany joined forces for strategic, structural, and content-specific initiatives aimed at implementing precision medicine in healthcare. Future trends in genomic engineering encompass its utilization in marine engineering for purposes such as the extraction of nutraceuticals from algae. Other emerging application domains include forensic sciences and personalized medicine. Next-generation sequencing (NGS) finds utility in DNA barcoding for the identification of fish larvae and eggs, alongside providing comprehensive descriptions of fish communities during the evaluation of fish populations. Genomics is progressively integrated into food quality and safety testing. Genome editing technologies play crucial roles in  AI in drug discovery as well as the diagnosis and treatment of human genetic disorders. Additionally, genome editing is employed in NGS, DNA analysis, profiling, and the genetic engineering of plants and animals. Consequently, as genomics continues to diversify its application areas, the demand for genome editing technologies is anticipated to rise in the forecast period. As a result, it is anticipated that throughout the projection period, demand for the Gene Prediction Tools Market will increase due to the increasing pressure among working individuals and Rising demand and increasing legalization of cannabis. Thus, driving the Gene Prediction Tools Market revenue. ## **Gene Prediction Tools Market Segment Insights** ### **Gene Prediction Tools Market Components Insights** The Gene Prediction Tools Market segmentation, based on Components, includes Software and Service. The software segment dominated the market, accounting for 58% of market revenue. The growth trajectory is shaped by advancing technologies and evolving global research requirements. For instance, to enhance gene prediction accuracy and functional annotation, algorithms are increasingly integrating multi-omics data, including transcriptomics, epigenomics, and proteomics. Integrating multiple layers of omics data enables a deeper comprehension of gene regulation and functional connections. Continuous endeavors to enhance gene prediction accuracy represent pivotal advancements in software development. Furthermore, addressing the challenges of handling complex genomic data and designing user-friendly and educational interfaces for academics and clinicians would further drive demand. **Figure 1: Gene Prediction Tools Market, by Components, 2023 & 2032 (USD Billion)** **** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ### **Gene Prediction Tools Market Application Insights** The Gene Prediction Tools Market segmentation, based on Application, includes [Drug discovery](../../../reports/drug-discovery-services-market-5870) & designing, Diagnostics, and other applications. The drug discovery & designing segment dominated the market, accounting for 58% of market revenue. Complex disorders such as cancer, cardiovascular diseases, and neurological disorders are characterized by intricate genetic factors. Gene prediction tools are instrumental in researchers and pharmaceutical companies elucidating the genetic foundations of these diseases. Through the identification of pertinent genes and pathways, these tools enable the discovery of potential drug targets, thereby facilitating the development of more efficacious therapeutics. ### **Gene Prediction Tools Market End-user Insights** The Gene Prediction Tools Market segmentation, based on End-user, includes Research & academic institutes, Biotechnology companies, Hospitals & clinics, and Diagnostic laboratories. The research & academic institutes segment dominated the market, accounting for 60% of market revenue. Due to their involvement in genomics research and biological inquiries, academic institutes and research centers possess diverse needs for gene prediction tools. Accurately pinpointing genes within a genome, annotating their attributes, and projecting their functions are essential tasks facilitated by gene prediction methodologies. These tools play a pivotal role in comprehending the genetic composition of species and exploring their evolutionary connections. ### **Gene Prediction Tools Market Regional Insights** By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Gene Prediction Tools market in North America can be attributed to several key factors. The escalating demand for gene prediction tools in the United States can be attributed to the country's burgeoning genomic research landscape. With a thriving community dedicated to genomics research, encompassing initiatives such as genome sequencing, genetic disease exploration, and population genetics studies, the need for advanced tools has grown significantly. The National Institutes of Health's All of Us Research Program, boasting nearly 100,000 diverse whole genome sequences, exemplifies this trend. Additionally, the Government of Canada's investment of $15 million over five years in the Pan-Canadian Genomic Library marks its inaugural step toward establishing a national, centralized genomic data management system. This initiative aims to enable healthcare professionals to securely capture, store, and access Canadian data equitably and sustainably. Gene prediction software plays a pivotal role in delineating gene architectures, regulatory elements, and functional annotations within extensive genomic datasets. Consequently, with the expansion of genomics research and applications, the demand for gene prediction software is expected to surge in the United States. Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. **Figure 2: GENE PREDICTION TOOLS MARKET SHARE BY REGION 2023 (USD Billion)** **** Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review Europe's Gene Prediction Tools Market accounts for the second-largest market share, as Europe has led the way in genomic research and technological advancements. The ongoing progress in sequencing technologies and bioinformatics tools has spurred a growing need for precise and effective gene prediction tools. In response, the government has announced substantial investments, including up to £25 million in Medical Research Council-led funding for a four-year functional genomics initiative. This initiative, in collaboration with UK Research and Innovation and other stakeholders, aims to establish a globally competitive offering in functional genomics through partnerships with industry, leveraging existing infrastructure and the expertise of UK researchers. Further, the German Gene Prediction Tools Market held the largest market share, and the UK Gene Prediction Tools Market was the fastest-growing market in the European region. The Asia-Pacific Gene Prediction Tools Market is expected to grow at the fastest CAGR from 2025 to 2034. Increased healthcare expenditure, growing research endeavors, advancements in technology, and the proliferation of various research tools are driving the expansion of the gene prediction tool market in the region. India facilitates 100% Foreign Direct Investment (FDI) through the automatic route for greenfield pharmaceuticals and medical device manufacturing, eliminating the need for government approval for non-resident or Indian companies. In December 2023, the Gujarat Chief Minister inaugurated the 'Start-Up Product Launch' event, showcasing innovative products developed by startups like Bioscan, SynerSense, Iota, and STRUmed Solutions during the 10th Vibrant Gujarat Global Summit. The Pre-Summit also witnessed the signing of a Memorandum of Understanding (MoU) between Indus Setu Global Foundation and Gujarat State Biotechnology Mission. Additionally, in November 2023, Bharat Biotech entered into an MoU with the University of Sydney Infectious Diseases Institute (Sydney ID) to collaborate on vaccine research initiatives, strengthening academic-industry partnerships. Moreover, China’s Gene Prediction Tools Market held the largest market share, and the Indian Gene Prediction Tools Market was the fastest-growing market in the Asia-Pacific region. ## **Gene Prediction Tools Key Market Players & Competitive Insights** Leading market players are investing heavily in research and development to expand their product lines, which will help the Gene Prediction Tools market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Gene Prediction Tools industry must offer cost-effective items. Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Gene Prediction Tools industry to benefit clients and increase the market sector. In recent years, the Gene Prediction Tools industry has offered some of the most significant advantages to the fields of healthcare, biotechnology, and genomic research. Major players in the Gene Prediction Tools Market, including AzoLifeScience, Softberry Technologies, DNASTAR, Qiagen NV, Illumina, Inc., BGI Genomics, Genscript, Exiqon, Geneious, Thermo Fisher Scientific, Inc. are attempting to increase market demand by investing in research and development operations. Thermo Fisher Scientific Inc. is a leading provider of medical equipment, analytical instruments, reagents, consumables, software, and services designed to address complex analytical challenges across research, diagnostics, and clinical laboratories. Their offerings encompass solutions for cellular analysis, biology, flow cytometry, and synthetic biology. The company boasts a diverse product range, including technologies for mass spectrometry, genetic sequencing, electron microscopy, protein research, and molecular biology. Thermo Fisher serves a wide spectrum of clients, including pharmaceutical and biotech companies, academic and research institutions, clinical diagnostic labs, government agencies, as well as the environmental and industrial quality and process control sectors. They distribute their products and services through direct sales, e-commerce platforms, and third-party distributors across the Americas, Asia-Pacific, and Europe. Thermo Fisher, headquartered in Waltham, Massachusetts, USA, recently announced the introduction of the Gibco CTS AAV-MAX Helper-Free AAV Production System in November 2022. This comprehensive solution is tailored for commercial and clinical applications related to AAV-based gene therapies. Illumina Inc. specializes in providing genomic sequencing and array-based solutions for genetic analysis across various sectors, including molecular diagnostics, translational and consumer genomics, and cancer research. Their product portfolio includes sequencing kits, reagents, tools, and systems, as well as microarray kits, molecular biology reagents, and arrays. Illumina offers services such as human whole-genome sequencing, microarray services, and instrument services alongside training and consulting. Their clientele includes pharmaceutical companies, academic institutions, genomic research centers, biotechnology firms, and clinical research organizations. The company distributes its products through direct sales and a network of distributors spanning the Americas, Asia-Pacific, Europe, the Middle East, and Africa. Illumina is headquartered in San Diego, California, USA. ### **Key companies in the Gene Prediction Tools Market include** - [AzoLifeScience](https://www.azolifesciences.com/article/Gene-Identification-Tools-in-Bioinformatics.aspx#:~:text=ORPHEUS%3A%20This%20software%20is%20used,predict%20genes%20in%20anonymous%20DNA.) - Softberry Technologies - DNASTAR - Qiagen NV - Illumina, Inc. - BGI Genomics - Genscript - Exiqon - Geneious - [Thermo Fisher Scientific, Inc.](https://www.thermofisher.com/in/en/home/life-science/genome-editing.html) ## **Gene Prediction Tools Industry Developments** **November 2022:** DNASTAR announced the release of Lasergene 17.4, which introduces an array of added functionalities focused on variant analysis for multiple sequence alignments. **June 2023:** Illumina, Inc. unveiled the Al software designed for predicting genetic mutations responsible for patient diseases. This move has bolstered the company's product lineup and contributed to its revenue expansion. ## **Gene Prediction Tools** **Market Segmentation** ### **Gene Prediction Tools Market Component Outlook** - Software - Service ### **Gene Prediction Tools Market Application Outlook** - Drug discovery & designing - Diagnostics - Other applications ### **Gene Prediction Tools Market End-user Outlook** - Research & academic institutes - Biotechnology companies - Hospitals & clinics - Diagnostic laboratories ### **Gene Prediction Tools Market** **Regional Outlook** ## Market Drivers ### Advancements in Bioinformatics The Gene Prediction Tools Market is significantly influenced by advancements in bioinformatics. As computational methods evolve, the ability to analyze vast amounts of genetic data has improved dramatically. This evolution allows researchers to utilize sophisticated algorithms for gene prediction, enhancing accuracy and efficiency. The bioinformatics market is expected to reach a valuation of several billion dollars, indicating a robust growth trajectory. These advancements not only streamline the research process but also facilitate the development of personalized medicine approaches. Thus, the Gene Prediction Tools Market stands to benefit from these technological innovations, as they enable more precise and reliable gene predictions. ### Increased Investment in Healthcare The Gene Prediction Tools Market is bolstered by increased investment in healthcare, particularly in genomics and biotechnology sectors. Governments and private entities are channeling substantial funds into research and development, aiming to foster innovation in gene prediction technologies. This influx of capital is expected to enhance the capabilities of existing tools and lead to the creation of novel solutions. For instance, funding for genomic research has seen a notable rise, with billions allocated annually. Such financial support is likely to accelerate advancements in the Gene Prediction Tools Market, making it a focal point for future healthcare solutions. ### Rising Demand for Genomic Research The Gene Prediction Tools Market is experiencing a surge in demand driven by the increasing focus on genomic research. As researchers and institutions strive to understand genetic variations and their implications on health, the need for advanced gene prediction tools becomes paramount. According to recent data, the market for genomic research tools is projected to grow at a compound annual growth rate of over 10% in the coming years. This growth is fueled by the rising prevalence of genetic disorders and the need for effective diagnostic tools. Consequently, the Gene Prediction Tools Market is likely to expand as more organizations invest in technologies that enhance their research capabilities and improve patient outcomes. ### Growing Awareness of Genetic Testing The Gene Prediction Tools Market is benefiting from the growing awareness of genetic testing among consumers and healthcare providers. As individuals become more informed about the implications of their genetic makeup, the demand for tools that can accurately predict gene functions and interactions is increasing. This trend is reflected in the rising number of genetic tests being conducted, which has seen a significant uptick in recent years. Consequently, the Gene Prediction Tools Market is poised for growth as more stakeholders recognize the value of predictive analytics in genetics, leading to improved health management and disease prevention strategies. ### Regulatory Support for Genomic Innovations The Gene Prediction Tools Market is positively impacted by regulatory support aimed at fostering genomic innovations. Regulatory bodies are increasingly recognizing the importance of genomics in healthcare and are establishing frameworks that facilitate the development and approval of gene prediction tools. This supportive environment encourages companies to invest in research and development, knowing that their innovations will have a clearer pathway to market. As a result, the Gene Prediction Tools Market is likely to see a proliferation of new products and services, enhancing the overall landscape of genetic research and application. ## Future Outlook The Gene Prediction Tools Market is projected to grow at an 18.2% CAGR from 2025 to 2035, driven by advancements in genomics, increasing demand for personalized medicine, and technological innovations. **New opportunities:** - Development of AI-driven predictive analytics platforms for gene sequencing. - Expansion of cloud-based gene analysis services for remote accessibility. - Partnerships with biotech firms to enhance gene editing technologies. By 2035, the Gene Prediction Tools Market is expected to be a pivotal sector in biotechnology. ## Segment Insights ### By Components: Software (Largest) vs. Service (Fastest-Growing) In the Gene Prediction Tools Market, the components segment showcases a competitive landscape where software solutions currently dominate the market share. Software tools are widely utilized by researchers and healthcare professionals for their efficiency and accuracy in predicting gene functionalities. This segment is backed by a broad range of applications, including genomic studies, personalized medicine, and biotechnology, making it integral to the advancement of genetic research. On the other hand, the service component is gaining traction, thanks to the increasing demand for customized analysis and consulting services tailored to specific gene-related projects. Software (Dominant) vs. Service (Emerging) The Software segment in the Gene Prediction Tools Market is characterized by robust usability and a wide array of features that cater to end-users across various sectors, including academic research and pharmaceuticals. These tools often incorporate advanced algorithms and user-friendly interfaces, which enhance the overall efficiency and accuracy of gene prediction initiatives. Conversely, the Service segment is considered an emerging player in this market, providing specialized consultancy and tailored support to organizations seeking to navigate complex genomic landscapes. This trend is fueled by the growing need for expert guidance in leveraging gene prediction tools, enabling clients to extract actionable insights and drive innovation in their projects. ### By Application: Drug Discovery & Designing (Largest) vs. Diagnostics (Fastest-Growing) In the Gene Prediction Tools Market, the application segment is defined primarily by three key areas: drug discovery & designing, diagnostics, and other applications. Among these, drug discovery and designing holds the largest market share, driven by the increasing need for personalized medicine and the efficiency it offers in pharmaceutical development. Meanwhile, diagnostics is seen to be rapidly gaining traction as healthcare professionals increasingly adopt genomic technologies for disease identification, thus carving out a significant portion of the market for itself, thanks to the rise in genetic disorders and preventive healthcare practices. The growth trends within this segment are notably influenced by advancements in bioinformatics and machine learning, which enhance the accuracy and speed of gene prediction tools used in both drug development and diagnostic testing. Drug discovery is propelled by the push towards more targeted therapeutic treatments, while diagnostics is spurred by technological innovations that simplify the integration of genetic data into routine clinical practices. This dual momentum is creating a dynamic landscape where both fields are expanding, albeit at different paces and with distinct driving forces. Drug Discovery & Designing (Dominant) vs. Diagnostics (Emerging) The drug discovery and designing segment is characterized by its essential role in the pharmaceutical industry, utilizing gene prediction tools to streamline the development of new therapeutics. This segment is recognized for its pioneering advancements that significantly shorten development timelines and reduce costs associated with traditional drug discovery processes. In contrast, the diagnostics segment has emerged rapidly, leveraging gene prediction tools to enhance disease identification and treatment personalization. With a focus on precision medicine, this segment is increasingly integrated into everyday clinical workflows and is becoming crucial for proactive healthcare solutions. Both segments are essential to the overall growth and innovation in the gene prediction tools market, serving complementary yet distinct needs within the broader healthcare landscape. ### By End-user: Biotechnology companies (Largest) vs. Research & academic institutes (Fastest-Growing) In the Gene Prediction Tools Market, the distribution of market share among end-user segments illustrates significant diversity. Biotechnology companies lead this sphere, leveraging gene prediction tools for research and development of novel therapies and treatments. Meanwhile, research and academic institutes exhibit a notable share, focusing on advancing genomic research and education. Hospitals and clinics primarily utilize these tools for personalized medicine applications, while diagnostic laboratories enhance their offerings through innovative gene analysis technologies. Research & academic institutes (Emerging) vs. Diagnostic laboratories (Dominant) Research and academic institutes are becoming increasingly crucial in the Gene Prediction Tools Market, symbolizing the emerging trend of academic research fueling innovation in genomics. Their role involves the exploration of genetic information to advance our understanding of disease mechanisms. Conversely, diagnostic laboratories remain dominant players, vital for transforming genomic insights into clinical applications. They typically integrate gene prediction tools to enhance diagnostic accuracy and evolve their testing panels. Together, these segments drive the market toward more tailored healthcare solutions, responding to the growing demand for precision medicine. ## Regional Market Share Analysis ### North America : Innovation and Research Hub North America dominates the Gene Prediction Tools Market, accounting for approximately 45% of the global share. The region's growth is driven by robust investments in biotechnology and genomics, alongside supportive regulatory frameworks that encourage innovation. The increasing prevalence of genetic disorders and the rising demand for personalized medicine further fuel market expansion. The United States is the largest market, with significant contributions from companies like Illumina and Thermo Fisher Scientific. Canada also plays a vital role, focusing on research and development in genomics. The competitive landscape is characterized by a mix of established players and emerging startups, fostering a dynamic environment for innovation. ### Europe : Emerging Regulatory Frameworks Europe is witnessing significant growth in the Gene Prediction Tools Market, holding around 30% of the global share. The region benefits from stringent regulatory frameworks that promote high standards in genetic research and product development. The increasing focus on precision medicine and advancements in genomics are key drivers of market demand. Leading countries include Germany, the UK, and France, which are home to major players like Qiagen and Bio-Rad Laboratories. The competitive landscape is evolving, with a mix of established firms and innovative startups. Collaborative efforts between academia and industry are also enhancing research capabilities, positioning Europe as a vital player in the global market. ### Asia-Pacific : Rapid Growth and Adoption Asia-Pacific is rapidly emerging as a significant player in the Gene Prediction Tools Market, accounting for approximately 20% of the global share. The region's growth is driven by increasing investments in healthcare infrastructure, rising awareness of genetic disorders, and government initiatives promoting biotechnology research. Countries like China and India are at the forefront of this expansion, supported by favorable regulatory environments. China is the largest market in the region, with substantial contributions from local companies and international players. India is also gaining traction, focusing on research and development in genomics. The competitive landscape is characterized by a mix of established firms and innovative startups, fostering a vibrant ecosystem for gene prediction tools. ### Middle East and Africa : Emerging Market Potential The Middle East and Africa region is gradually developing its Gene Prediction Tools Market, currently holding about 5% of the global share. The growth is driven by increasing investments in healthcare and biotechnology, alongside rising awareness of genetic research. Governments are beginning to recognize the importance of genomics in healthcare, leading to supportive policies and funding initiatives. Countries like South Africa and the UAE are leading the way, with growing interest from both local and international companies. The competitive landscape is still in its nascent stages, but there is a clear trend towards collaboration between research institutions and industry players, which is essential for market growth. ## Competitive Benchmarking The Gene Prediction Tools Market is currently characterized by a dynamic competitive landscape, driven by rapid advancements in genomics and increasing demand for personalized medicine. Key players such as Illumina (US), Thermo Fisher Scientific (US), and Qiagen (DE) are at the forefront, leveraging their technological prowess to enhance product offerings. Illumina (US) focuses on innovation in sequencing technologies, while Thermo Fisher Scientific (US) emphasizes comprehensive solutions for genetic analysis. Qiagen (DE) is strategically positioned through its robust bioinformatics capabilities, which complement its gene prediction tools. Collectively, these strategies foster a competitive environment that prioritizes technological advancement and customer-centric solutions. In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive innovation. This competitive structure suggests that while smaller firms may struggle to compete on scale, they can still carve out niches through specialized offerings or innovative technologies. In August 2025, Illumina (US) announced a partnership with a leading healthcare provider to integrate its gene sequencing technology into routine clinical practice. This strategic move is likely to enhance patient outcomes by facilitating earlier disease detection and personalized treatment plans. Such collaborations indicate a shift towards more integrated healthcare solutions, positioning Illumina as a leader in the application of genomic data in clinical settings. In September 2025, Thermo Fisher Scientific (US) launched a new suite of bioinformatics tools designed to streamline data analysis for gene prediction. This initiative not only enhances their product portfolio but also reflects a growing trend towards the integration of artificial intelligence in genomic research. By simplifying complex data interpretation, Thermo Fisher aims to empower researchers and clinicians, thereby solidifying its competitive edge in the market. In July 2025, Qiagen (DE) expanded its operations in Asia by establishing a new research facility focused on gene prediction technologies. This expansion is indicative of the company's strategy to tap into emerging markets, where demand for genomic solutions is rapidly increasing. By investing in regional capabilities, Qiagen is likely to enhance its market presence and foster innovation tailored to local needs. As of October 2025, the Gene Prediction Tools Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will increasingly hinge on technological advancements and supply chain reliability, rather than solely on price. Companies that prioritize innovation and adaptability are likely to thrive in this evolving market. ## Recent News & Developments **November 2022:** DNASTAR announced the release of Lasergene 17.4, which introduces an array of added functionalities focused on variant analysis for multiple sequence alignments. **June 2023:** Illumina, Inc. unveiled the Al software designed for predicting genetic mutations responsible for patient diseases. This move has bolstered the company's product lineup and contributed to its revenue expansion. ## **Gene Prediction Tools Market**  ## Report Scope | MARKET SIZE 2024 | 0.2477(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 0.2928(USD Billion) | | MARKET SIZE 2035 | 1.559(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 18.2% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Illumina (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Qiagen (DE), Ginkgo Bioworks (US), Boehringer Ingelheim (DE), Genomatix (DE), DNAnexus (US), Geneious (NZ) | | Segments Covered | Component, Application, End-user, Region | | Key Market Opportunities | Advancements in artificial intelligence enhance accuracy and efficiency in the Gene Prediction Tools Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Gene Prediction Tools Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Gene Prediction Tools Market by 2035?** A: The Gene Prediction Tools Market is projected to reach a valuation of 1.559 USD Billion by 2035. **Q: What was the market valuation of the Gene Prediction Tools Market in 2024?** A: In 2024, the market valuation of the Gene Prediction Tools Market was 0.2477 USD Billion. **Q: What is the expected CAGR for the Gene Prediction Tools Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Gene Prediction Tools Market during the forecast period 2025 - 2035 is 18.2%. **Q: Which companies are considered key players in the Gene Prediction Tools Market?** A: Key players in the Gene Prediction Tools Market include Illumina, Thermo Fisher Scientific, Agilent Technologies, and Bio-Rad Laboratories. **Q: What are the main components of the Gene Prediction Tools Market?** A: The main components of the Gene Prediction Tools Market are software and services, with software valued at 0.93545 USD Billion and services at 0.62355 USD Billion. **Q: What applications are driving growth in the Gene Prediction Tools Market?** A: The applications driving growth include drug discovery and designing, diagnostics, and other applications, with drug discovery valued at 0.6 USD Billion. **Q: Who are the primary end-users of Gene Prediction Tools?** A: Primary end-users of Gene Prediction Tools include research and academic institutes, biotechnology companies, hospitals and clinics, and diagnostic laboratories. **Q: What was the valuation of the diagnostics segment in the Gene Prediction Tools Market in 2024?** A: In 2024, the diagnostics segment of the Gene Prediction Tools Market was valued at 0.0877 USD Billion. **Q: How does the Gene Prediction Tools Market compare across different end-user segments?** A: The Gene Prediction Tools Market shows comparable valuations across end-user segments, with research and academic institutes and biotechnology companies both valued at 0.4665 USD Billion. **Q: What trends are influencing the Gene Prediction Tools Market as it moves towards 2035?** A: Trends influencing the Gene Prediction Tools Market include advancements in technology and increasing demand for personalized medicine, which may drive further growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gene-prediction-tools-market-21869*